IST

Novelis to Host Fourth Quarter and Full Fiscal Year 2024 Earnings Conference Call on May 6

Retrieved on: 
Monday, April 29, 2024
EDT, Telephone, Webcast, Novelis, PIN, IST

ATLANTA, April 29, 2024 /PRNewswire/ -- Novelis Inc. will report its earnings for the fourth quarter and full fiscal year 2024 on Monday, May 6, 2024.

Key Points: 
  • ATLANTA, April 29, 2024 /PRNewswire/ -- Novelis Inc. will report its earnings for the fourth quarter and full fiscal year 2024 on Monday, May 6, 2024.
  • Following the release, Steve Fisher, president and chief executive officer, and Dev Ahuja, chief financial officer, will discuss the results via a live conference call for investors at 7:00 a.m. EDT / 4:30 p.m. IST the same day.
  • The conference call will also be webcast live via the Novelis website, with presentation materials available online at https://investors.novelis.com/ .
  • The webcast can be accessed live at: https://links.ccwebcast.com/?EventId=NOV060524
    To participate by telephone, participants are requested to register at: https://services.choruscall.in/DiamondPassRegistration/register?confirma...
    Upon registering you will receive the dial-in info and a unique PIN to join the call as well as an email confirmation with the details.

Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024

Retrieved on: 
Monday, April 29, 2024
Internet, Telephone, Webcast, IST

DUBLIN, April 29, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 13, 2024.

Key Points: 
  • DUBLIN, April 29, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 13, 2024.
  • An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm ET (2:00 pm PT/10:00 pm IST) that day.
  • Those interested in listening to the conference call live via the internet may do so by visiting Theravance Biopharma's website at www.theravance.com , under the Investors section, Events and Presentations.
  • A replay of the webcast will be available on Theravance Biopharma's website for 30 days through June 12, 2024.

MakeMyTrip Limited to report Fiscal 2024 Fourth Quarter and Full Year Financial & Operating Results on May 15, 2024

Retrieved on: 
Thursday, May 2, 2024
Transportation, Vacation, Lodging, Cruise, Destinations, Travel, EDT, Zoom, IST

MakeMyTrip Limited (Nasdaq: MMYT) plans to report its fiscal 2024 fourth quarter and full year financial and operating results before markets open on Wednesday, May 15, 2024.

Key Points: 
  • MakeMyTrip Limited (Nasdaq: MMYT) plans to report its fiscal 2024 fourth quarter and full year financial and operating results before markets open on Wednesday, May 15, 2024.
  • The company will post the release on its Investor Relations website https://investors.makemytrip.com/ and will not distribute over newswires.
  • A live Zoom Webinar with the senior management team will also be hosted on May 15, 2024, at 7:30 am EDT or 5:00 pm IST through the company’s Investor Relations website at https://investors.makemytrip.com/ .
  • A replay of the event will be available on the company’s Investor Relations website approximately two hours after the conclusion of the live event.

E Ink Teams Up with Ecosystem Partners to Develop Next-Generation ePaper Shelf Labels

Retrieved on: 
Monday, April 15, 2024
Data Management, Other Retail, Technology, Manufacturing, Supermarket, Other Technology, Other Manufacturing, Apps, Applications, Retail, Software, Textiles, LCD, ESL, Realtek, Anisotropic conductive film, Ecosystem, Glass, SOP, ACF, IST, SOC, Ink, Carbon, Gold, Multimedia, Polychlorinated biphenyl, E Ink, Knowledge, CGA, Architecture, Printed circuit board

This technology will be integrated into the next-generation electronic shelf label (ESL) jointly developed with the system integrator, SOLUM.

Key Points: 
  • This technology will be integrated into the next-generation electronic shelf label (ESL) jointly developed with the system integrator, SOLUM.
  • "Replacing paper labels with ePaper shelf labels brings higher efficiency and lower energy consumption to retailers,” said Johnson Lee, CEO of E Ink.
  • We worked together to develop technology to realize the potential of SoP on ePaper panels and to drive the next generation electronic shelf label.
  • If the information is updated four times a day, the carbon dioxide emissions generated by using paper labels are 32,000 times higher than ePaper labels.

Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024

Retrieved on: 
Wednesday, April 17, 2024
IST, Jazz Pharmaceuticals, Interest

DUBLIN, April 17, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2024 first quarter financial results on Wednesday, May 1, 2024, after the close of the U.S. financial markets.

Key Points: 
  • DUBLIN, April 17, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2024 first quarter financial results on Wednesday, May 1, 2024, after the close of the U.S. financial markets.
  • ET / 9:30 p.m. IST to discuss 2024 first quarter financial results and provide a business and financial update.
  • Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations .
  • To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast.

Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024

Retrieved on: 
Wednesday, April 17, 2024
IST, Jazz Pharmaceuticals, Interest

DUBLIN, April 17, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2024 first quarter financial results on Wednesday, May 1, 2024, after the close of the U.S. financial markets.

Key Points: 
  • DUBLIN, April 17, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2024 first quarter financial results on Wednesday, May 1, 2024, after the close of the U.S. financial markets.
  • ET / 9:30 p.m. IST to discuss 2024 first quarter financial results and provide a business and financial update.
  • Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations .
  • To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast.

Agenus Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, March 14, 2024
Biotechnology, Pharmaceutical, Health, Oncology, OS, BOT, Colitis, Inc., Colorectal cancer, PD, RECIST, IST, Partnership, RAS, Patient, MSI, FOLFIRINOX, BMS, Melanoma, MSS, BAL, Cancer, CRC, NLM, TIGIT, Liver disease, Pharmaceutical industry

Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today provided a corporate update and reported financial results for the fourth quarter and full year 2023.

Key Points: 
  • Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today provided a corporate update and reported financial results for the fourth quarter and full year 2023.
  • “In 2023, Agenus made significant advances across our BOT/BAL development program.
  • $25 million milestone payment from BMS triggered by the commencement of a Phase 2 study with BMS-986442 in December 2023.
  • For the fourth quarter ended December 31, 2023, we recognized revenue of $84 million and incurred a net loss of $49 million or $0.13 per share.

My Clinic Receives Healthcare Tech-Contact Excellence Award from IST Networks & Genesys

Retrieved on: 
Monday, March 25, 2024
Cloud, Clinic, Health, Organization, Motivation, IST, Partnership, Patient, Salesforce, Social media, Health care, Kingdom, Vision 2030, Patient satisfaction, Platinum, Human, Nursing

RIYADH, Saudi Arabia, March 25, 2024 /PRNewswire/ -- My Clinic, a leading healthcare provider in the Kingdom of Saudi Arabia, has been honored with the prestigious Healthcare Tech-Contact Excellence Award by IST Networks and Genesys.

Key Points: 
  • RIYADH, Saudi Arabia, March 25, 2024 /PRNewswire/ -- My Clinic, a leading healthcare provider in the Kingdom of Saudi Arabia, has been honored with the prestigious Healthcare Tech-Contact Excellence Award by IST Networks and Genesys.
  • As the Genesys partner of choice for implementing this innovative solution in healthcare, IST Networks, a platinum Genesys partner, has demonstrated its expertise in transforming patient care through technology.
  • My Clinic has implemented the Genesys Cloud along with an integration with Salesforce, featuring channels like voice, messaging, email, and social engagement.
  • "We are profoundly honored to receive the Healthcare Tech-Contact Excellence Award from IST Networks and Genesys, a recognition that reflects our unwavering commitment to revolutionizing patient care through technology.

My Clinic Receives Healthcare Tech-Contact Excellence Award from IST Networks & Genesys

Retrieved on: 
Monday, March 25, 2024
Cloud, Clinic, Health, Organization, Motivation, IST, Partnership, Patient, Salesforce, Social media, Health care, Kingdom, Vision 2030, Patient satisfaction, Platinum, Human, Nursing

RIYADH, Saudi Arabia, March 25, 2024 /PRNewswire/ -- My Clinic, a leading healthcare provider in the Kingdom of Saudi Arabia, has been honored with the prestigious Healthcare Tech-Contact Excellence Award by IST Networks and Genesys.

Key Points: 
  • RIYADH, Saudi Arabia, March 25, 2024 /PRNewswire/ -- My Clinic, a leading healthcare provider in the Kingdom of Saudi Arabia, has been honored with the prestigious Healthcare Tech-Contact Excellence Award by IST Networks and Genesys.
  • As the Genesys partner of choice for implementing this innovative solution in healthcare, IST Networks, a platinum Genesys partner, has demonstrated its expertise in transforming patient care through technology.
  • My Clinic has implemented the Genesys Cloud along with an integration with Salesforce, featuring channels like voice, messaging, email, and social engagement.
  • "We are profoundly honored to receive the Healthcare Tech-Contact Excellence Award from IST Networks and Genesys, a recognition that reflects our unwavering commitment to revolutionizing patient care through technology.

Air Samarkand Announces Launch of Scheduled Flights and Appointment of New CEO

Retrieved on: 
Monday, March 18, 2024
CFM International, Noise, Samarkand International Airport, IST, Airbus, Travel, A321, Neo, SKD, City, Tourism, A330, Safety, Atmosphere of Earth, Airport, Airbus A320neo family, Airline

SAMARKAND, Uzbekistan, March 18, 2024 /PRNewswire/ -- Air Samarkand is to commence its scheduled flight programme on Thursday, 21st March, operating on the Samarkand - Istanbul - Samarkand route with its Airbus A321neo aircraft.

Key Points: 
  • SAMARKAND, Uzbekistan, March 18, 2024 /PRNewswire/ -- Air Samarkand is to commence its scheduled flight programme on Thursday, 21st March, operating on the Samarkand - Istanbul - Samarkand route with its Airbus A321neo aircraft.
  • Istanbul airport also offers extensive onward travel opportunities to cities worldwide, and Air Samarkand plans to add further flight options on the city pairing in the near future.
  • Based at Samarkand International Airport, Air Samarkand has been founded to support a major tourism and commercial drive for the historic city of Samarkand.
  • Currently he is also CEO of Silk Road Samarkand, the first multi-functional international tourism centre in Asia.